C5AR1 抗体 (PE)
Quick Overview for C5AR1 抗体 (PE) (ABIN2472751)
抗原
See all C5AR1 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
- 
    - 
                                            产品特性
- Purified IgG conjugated to R. Phycoerythrin (RPE)
- 
                                            亚型
- IgG2b
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- Optimal working dilution should be determined by the investigator.
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Lyophilized
 
- 
                                            
- 
    - 
                                            : "Pharmacological targeting of anaphylatoxin receptors during the effector phase of allergic asthma suppresses airway hyperresponsiveness and airway inflammation."    in: Journal of immunology (Baltimore, Md. : 1950), Vol. 174, Issue 2, pp. 783-9, (2005)         (PubMed).        
 : "C5a initiates the inflammatory cascade in immune complex peritonitis." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 173, Issue 5, pp. 3437-45, (2004) (PubMed).
 : "Characterization of C5aR expression on murine myeloid and lymphoid cells by the use of a novel monoclonal antibody." in: Immunology letters, Vol. 88, Issue 1, pp. 47-52, (2003) (PubMed).
 
 
- 
                                            : "Pharmacological targeting of anaphylatoxin receptors during the effector phase of allergic asthma suppresses airway hyperresponsiveness and airway inflammation."    in: Journal of immunology (Baltimore, Md. : 1950), Vol. 174, Issue 2, pp. 783-9, (2005)         (PubMed).        
- 
    - C5AR1 (Complement Component 5a Receptor 1 (C5AR1))
- 
                                            别名
- CD88
- 
                                            背景
- Synonyms: C5aR
- 
                                            基因ID
- 12273
- 
                                            UniProt
- P30993
- 
                                            途径
- Complement System
 抗原
- 
                    
 
                                     
                                     
                                    